Inverness Medical introduces new TechLab[R] C.diff Quik Chek Complete[tm] at Inverness Medical

Inverness Medical is pleased to announce the launch of the new TechLab C.diff Quik Chek Complete™ rapid test as an in vitro diagnostic aid for Clostridium difficile associated disease (CDAD).

C. difficile is responsible for the most common form of hospital-acquired diarrhoea and antibiotic associated colitis. Although primarily a hospital acquired disease, C. difficile infection is increasingly occurring in community outpatient settings. This is causing a major problem for hospital and community care settings because the number of patients at risk of C. difficile infection is substantial. Highly infectious and extremely dangerous in the immunocompromised or elderly patients, Clostridium difficile infection can be life threatening.

TECHLAB® C. DIFF QUIK CHEK COMPLETE™ test detects glutamate dehydrogenase (GDH) and C. difficile toxins A and B in one simple assay, and can be used for screening while confirming the presence of toxigenic C.difficile strains. C. difficile antigen glutamate dehydrogenase (GDH) is common to all strains of C. difficile and has been identified as an excellent screening marker for the infection. The TECHLAB® C. DIFF QUIK CHEK COMPLETE™ test provides the COMPLETE picture.

> Read the full article below <

Read the rest of this article in your chosen speciality:

• Microbiology|
• Primary Care Services

• 1|
• 2|
• 3|
• 4